Sarah Romano Net Worth & Insider Trades

Sarah Romano - Chief Financial Officer, Eyegate Pharmaceuticals Inc

As of November 3, 2021

What is Sarah Romano's Net Worth?

The current estimated net worth of Eyegate Pharmaceuticals Inc's Chief Financial Officer, Sarah Romano, is estimated to be about $761.07K . Sarah Romano owns about 262,113 units of Eyegate Pharmaceuticals Inc common stock. In the last 4 years at Eyegate Pharmaceuticals Inc, Sarah Romano has sold an estimated value of $26.67K worth.

What is Sarah Romano's Past Insider Trading?

Sarah Romano's largest purchase order was 10,000 units , worth over $10K on August 17, 2017. Sarah Romano's largest sale order was 19,750 units , worth over $4.67K on July 15, 2019. In total, Sarah Romano has made about 38 transactions over 4 years of their time at Eyegate Pharmaceuticals Inc. Sarah Romano usually trades in February, with the busiest year in 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Price per Share
Filing Date
No matching records found


Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What was Sarah Romano's Salary in 2020 ?

As Chief Financial Officer of Eyegate Pharmaceuticals Inc, Sarah Romano has a total base salary of $264,361 . Sarah Romano received compensation valued at about $453,643 in 2020 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of a bonus of $60,000 , stock awards of $64,641 , option awards of $64,641 , and

What is Sarah Romano's' Mailing Address?

  • Mailing address is 271 Waverly Oaks Road Waltham MA 02452 MA

Eyegate Pharmaceuticals Inc Executive Compensation

Stock Awards
Option Awards
Other Compensation
Stephen From 2020 $400,000 $160,000 $129,282 $193,923 - $883,205
Stephen From 2019 $400,000 $106,600 - $94,740 - $601,340
Sarah Romano 2020 $264,361 $60,000 $64,641 $64,641 - $453,643
Sarah Romano 2019 $250,000 $86,010 - $23,685 - $359,695
Michael Manzo 2020 $250,000 $60,000 $48,481 $48,481 - $406,962
Michael Manzo 2019 $250,000 $94,167 - $23,685 - $367,852
No matching records found


What are Eyegate Pharmaceuticals Inc's Past Insider Trades?

Eyegate Pharmaceuticals Inc's most recent insider trade came on August 3, 2021 by Armistice Capital Llc, Armistice Capital Master Fund Ltd and Steven Boyd who sold 260,963 units worth $646.61K . In the last 6 years, insiders at Eyegate Pharmaceuticals Inc have sold an estimated value of $15.73M and bought an estimated value of $20.29M worth of shares. Insider trading is most common in February, with the busiest year in 2020. The most active traders at the company are Stephen From, Executive Chairman,  Michael Manzo, VP Engineering,  and Brenda Mann, VP Research & Development .


Date Range: All Time
Insider Names
Price per Share
Filing Date
No matching records found